340 related articles for article (PubMed ID: 29730187)
1. Identification of proresolving and inflammatory lipid mediators in human psoriasis.
Sorokin AV; Norris PC; English JT; Dey AK; Chaturvedi A; Baumer Y; Silverman J; Playford MP; Serhan CN; Mehta NN
J Clin Lipidol; 2018; 12(4):1047-1060. PubMed ID: 29730187
[TBL] [Abstract][Full Text] [Related]
2. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.
Elajami TK; Colas RA; Dalli J; Chiang N; Serhan CN; Welty FK
FASEB J; 2016 Aug; 30(8):2792-801. PubMed ID: 27121596
[TBL] [Abstract][Full Text] [Related]
3. Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation.
Park KD; Kim N; Kang J; Dhakal H; Kim JY; Jang YH; Lee WJ; Lee SJ; Kim SH
Int Immunopharmacol; 2021 Sep; 98():107883. PubMed ID: 34153674
[TBL] [Abstract][Full Text] [Related]
4. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue.
Colas RA; Shinohara M; Dalli J; Chiang N; Serhan CN
Am J Physiol Cell Physiol; 2014 Jul; 307(1):C39-54. PubMed ID: 24696140
[TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of proresolving lipid mediators by vascular cells and tissues.
Chatterjee A; Komshian S; Sansbury BE; Wu B; Mottola G; Chen M; Spite M; Conte MS
FASEB J; 2017 Aug; 31(8):3393-3402. PubMed ID: 28442547
[TBL] [Abstract][Full Text] [Related]
6. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis.
Eickmeier O; Fussbroich D; Mueller K; Serve F; Smaczny C; Zielen S; Schubert R
PLoS One; 2017; 12(2):e0171249. PubMed ID: 28158236
[TBL] [Abstract][Full Text] [Related]
7. Metabololipidomic profiling of functional immunoresolvent clusters and eicosanoids in mammalian tissues.
Norris PC; Serhan CN
Biochem Biophys Res Commun; 2018 Oct; 504(3):553-561. PubMed ID: 29524409
[TBL] [Abstract][Full Text] [Related]
8. Maresins: Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases.
Tang S; Wan M; Huang W; Stanton RC; Xu Y
Mediators Inflamm; 2018; 2018():2380319. PubMed ID: 29674943
[TBL] [Abstract][Full Text] [Related]
9. A cluster of immunoresolvents links coagulation to innate host defense in human blood.
Norris PC; Libreros S; Chiang N; Serhan CN
Sci Signal; 2017 Aug; 10(490):. PubMed ID: 28765512
[TBL] [Abstract][Full Text] [Related]
10. Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.
Barden AE; Mas E; Croft KD; Phillips M; Mori TA
Am J Clin Nutr; 2015 Dec; 102(6):1357-64. PubMed ID: 26561623
[TBL] [Abstract][Full Text] [Related]
11. Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake.
Poulsen RC; Gotlinger KH; Serhan CN; Kruger MC
Am J Hematol; 2008 Jun; 83(6):437-45. PubMed ID: 18429055
[TBL] [Abstract][Full Text] [Related]
12. Human milk proresolving mediators stimulate resolution of acute inflammation.
Arnardottir H; Orr SK; Dalli J; Serhan CN
Mucosal Immunol; 2016 May; 9(3):757-766. PubMed ID: 26462421
[TBL] [Abstract][Full Text] [Related]
13. The roles of special proresolving mediators in pain relief.
Zhang LY; Jia MR; Sun T
Rev Neurosci; 2018 Aug; 29(6):645-660. PubMed ID: 29420307
[TBL] [Abstract][Full Text] [Related]
14. Bioactive Lipid Mediator Profiles in Human Psoriasis Skin and Blood.
Sorokin AV; Domenichiello AF; Dey AK; Yuan ZX; Goyal A; Rose SM; Playford MP; Ramsden CE; Mehta NN
J Invest Dermatol; 2018 Jul; 138(7):1518-1528. PubMed ID: 29454560
[TBL] [Abstract][Full Text] [Related]
15. Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics.
English JT; Norris PC; Hodges RR; Dartt DA; Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2017 Feb; 117():17-27. PubMed ID: 28237084
[TBL] [Abstract][Full Text] [Related]
16. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution.
Fredman G; Serhan CN
Biochem J; 2011 Jul; 437(2):185-97. PubMed ID: 21711247
[TBL] [Abstract][Full Text] [Related]
17. Formation of lipoxins and resolvins in human leukocytes.
Kahnt AS; Schebb NH; Steinhilber D
Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106726. PubMed ID: 36878381
[TBL] [Abstract][Full Text] [Related]
18. Resolution of inflammation in neuromyelitis optica spectrum disorders.
Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
[TBL] [Abstract][Full Text] [Related]
19. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation.
Mas E; Croft KD; Zahra P; Barden A; Mori TA
Clin Chem; 2012 Oct; 58(10):1476-84. PubMed ID: 22912397
[TBL] [Abstract][Full Text] [Related]
20. Aspirin-triggered proresolving mediators stimulate resolution in cancer.
Gilligan MM; Gartung A; Sulciner ML; Norris PC; Sukhatme VP; Bielenberg DR; Huang S; Kieran MW; Serhan CN; Panigrahy D
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6292-6297. PubMed ID: 30862734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
